Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Env"" wg kryterium: Temat


Tytuł:
Elicitation of Neutralizing Antibody Responses to HIV-1 Immunization with Nanoparticle Vaccine Platforms.
Autorzy:
Murji AA; Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN 37232, USA.; Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
Qin JS; Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN 37232, USA.; Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
Hermanus T; National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg 2131, South Africa.; Antibody Immunity Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg 2000, South Africa.
Morris L; National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg 2131, South Africa.; Antibody Immunity Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg 2000, South Africa.; Centre for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu-Natal, Durban 4041, South Africa.
Georgiev IS; Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN 37232, USA.; Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN 37232, USA.; Program in Computational Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN 37232, USA.; Vanderbilt Institute for Infection, Immunology and Inflammation, Vanderbilt University Medical Center, Nashville, TN 37232, USA.; Department of Electrical Engineering and Computer Science, Vanderbilt University, Nashville, TN 37232, USA.; Center for Structural Biology, Vanderbilt University, Nashville, TN 37232, USA.
Pokaż więcej
Źródło:
Viruses [Viruses] 2021 Jul 02; Vol. 13 (7). Date of Electronic Publication: 2021 Jul 02.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
AIDS Vaccines/*immunology
Antibodies, Neutralizing/*immunology
HIV Antibodies/*blood
HIV Infections/*prevention & control
HIV-1/*immunology
Nanoparticles/*administration & dosage
env Gene Products, Human Immunodeficiency Virus/*immunology
AIDS Vaccines/administration & dosage ; Animals ; Antibodies, Neutralizing/biosynthesis ; Female ; Guinea Pigs ; HIV Infections/immunology ; HIV-1/classification ; HIV-1/genetics ; Immunization ; Mice ; Mice, Inbred BALB C ; Nanoparticles/chemistry ; env Gene Products, Human Immunodeficiency Virus/classification ; env Gene Products, Human Immunodeficiency Virus/genetics
Czasopismo naukowe
Tytuł:
HIV-1 Envelope Conformation, Allostery, and Dynamics.
Autorzy:
Bennett AL; Duke Human Vaccine Institute, Durham, NC 27710, USA.
Henderson R; Duke Human Vaccine Institute, Durham, NC 27710, USA.; Department of Medicine, Duke University, Durham, NC 27710, USA.
Pokaż więcej
Źródło:
Viruses [Viruses] 2021 May 07; Vol. 13 (5). Date of Electronic Publication: 2021 May 07.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Review
MeSH Terms:
HIV Envelope Protein gp41/*chemistry
HIV-1/*genetics
env Gene Products, Human Immunodeficiency Virus/*chemistry
env Gene Products, Human Immunodeficiency Virus/*metabolism
Antibodies, Neutralizing/immunology ; HIV Antibodies/immunology ; HIV Envelope Protein gp41/genetics ; HIV Envelope Protein gp41/immunology ; HIV-1/chemistry ; HIV-1/immunology ; Models, Molecular ; Protein Binding ; Protein Conformation ; Protein Multimerization ; Virus Internalization ; env Gene Products, Human Immunodeficiency Virus/genetics ; env Gene Products, Human Immunodeficiency Virus/immunology
Czasopismo naukowe
Tytuł:
Super-Resolution STED Microscopy-Based Mobility Studies of the Viral Env Protein at HIV-1 Assembly Sites of Fully Infected T-Cells.
Autorzy:
Chojnacki J; MRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford OX3 9DS, UK.; IrsiCaixa AIDS Research Institute, University Hospital Germans Trias i Pujol, Ctra. de Canyet s/n, Badalona, 08916 Barcelona, Spain.
Eggeling C; MRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford OX3 9DS, UK.; Institute of Applied Optics and Biophysics, Friedrich-Schiller-University Jena, Max-Wien Platz 4, 07743 Jena, Germany.; Leibniz Institute of Photonic Technology e.V., Albert-Einstein-Straße 9, 07745 Jena, Germany.
Pokaż więcej
Źródło:
Viruses [Viruses] 2021 Apr 02; Vol. 13 (4). Date of Electronic Publication: 2021 Apr 02.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Virus Assembly*
HIV-1/*physiology
Microscopy/*methods
Microscopy, Fluorescence/*methods
env Gene Products, Human Immunodeficiency Virus/*chemistry
HEK293 Cells ; HIV-1/ultrastructure ; Humans ; Jurkat Cells ; Microscopy/instrumentation ; Molecular Dynamics Simulation ; env Gene Products, Human Immunodeficiency Virus/metabolism ; env Gene Products, Human Immunodeficiency Virus/ultrastructure ; gag Gene Products, Human Immunodeficiency Virus/metabolism
Czasopismo naukowe
Tytuł:
Mutations that confer resistance to broadly-neutralizing antibodies define HIV-1 variants of transmitting mothers from that of non-transmitting mothers.
Autorzy:
Kumar A; Duke Human Vaccine Institute, Duke University Medical Centre, Durham, North Carolina, United States of America.
Giorgi EE; Los Alamos National Laboratory, Los Alamos, New Mexico, United States of America.
Tu JJ; Duke Human Vaccine Institute, Duke University Medical Centre, Durham, North Carolina, United States of America.
Martinez DR; Duke Human Vaccine Institute, Duke University Medical Centre, Durham, North Carolina, United States of America.
Eudailey J; Duke Human Vaccine Institute, Duke University Medical Centre, Durham, North Carolina, United States of America.
Mengual M; Department of Medicine, Duke University Medical Centre, Durham, North Carolina, United States of America.
Honnayakanahalli Marichannegowda M; Department of Medicine, Duke University Medical Centre, Durham, North Carolina, United States of America.
Van Dyke R; Tulane University School of Medicine, New Orleans, Louisiana, United States of America.
Gao F; Department of Medicine, Duke University Medical Centre, Durham, North Carolina, United States of America.
Permar SR; Duke Human Vaccine Institute, Duke University Medical Centre, Durham, North Carolina, United States of America.; Department of Pediatrics, Weill Cornell Medicine, New York, New York, United States of America.
Pokaż więcej
Źródło:
PLoS pathogens [PLoS Pathog] 2021 Apr 02; Vol. 17 (4), pp. e1009478. Date of Electronic Publication: 2021 Apr 02 (Print Publication: 2021).
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
Genetic Variation*
Infectious Disease Transmission, Vertical*
Broadly Neutralizing Antibodies/*immunology
HIV Antibodies/*immunology
HIV Infections/*virology
HIV-1/*genetics
env Gene Products, Human Immunodeficiency Virus/*genetics
Female ; HIV Infections/transmission ; HIV-1/immunology ; HIV-1/physiology ; Humans ; Infant ; Mothers ; Phylogeny ; Pregnancy ; env Gene Products, Human Immunodeficiency Virus/immunology
Czasopismo naukowe
Tytuł:
Macaque interferon-induced transmembrane proteins limit replication of SHIV strains in an Envelope-dependent manner.
Autorzy:
Sharma A; Human Biology Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States of America.
McLaughlin RN Jr; Pacific Northwest Research Institute, Seattle, WA, United States of America.
Basom RS; Genomics and Bioinformatics Shared Resource, Fred Hutchinson Cancer Research Center, Seattle, WA, United States of America.
Kikawa C; Human Biology Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States of America.
OhAinle M; Human Biology Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States of America.
Yount JS; Department of Microbial Infection & Immunity, The Ohio State University, Columbus, OH, United States of America.
Emerman M; Human Biology Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States of America.
Overbaugh J; Human Biology Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States of America.
Pokaż więcej
Źródło:
PLoS pathogens [PLoS Pathog] 2019 Jul 01; Vol. 15 (7), pp. e1007925. Date of Electronic Publication: 2019 Jul 01 (Print Publication: 2019).
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
HIV-1/*pathogenicity
HIV-1/*physiology
Simian Immunodeficiency Virus/*pathogenicity
Simian Immunodeficiency Virus/*physiology
env Gene Products, Human Immunodeficiency Virus/*physiology
Adaptation, Physiological ; Animals ; Genes, env ; HIV-1/genetics ; Host Microbial Interactions/genetics ; Host Microbial Interactions/physiology ; Host Specificity ; Humans ; Interferon-alpha/metabolism ; Macaca nemestrina/genetics ; Macaca nemestrina/immunology ; Macaca nemestrina/virology ; Protein Processing, Post-Translational ; Reassortant Viruses/genetics ; Reassortant Viruses/pathogenicity ; Reassortant Viruses/physiology ; Simian Immunodeficiency Virus/genetics ; Virus Replication
Czasopismo naukowe
Tytuł:
Conformational plasticity underlies membrane fusion induced by an HIV sequence juxtaposed to the lipid envelope.
Autorzy:
de la Arada I; Instituto Biofisika (CSIC-UPV/EHU), University of the Basque Country (UPV/EHU), PO Box 644, 48080, Bilbao, Spain.
Torralba J; Instituto Biofisika (CSIC-UPV/EHU), University of the Basque Country (UPV/EHU), PO Box 644, 48080, Bilbao, Spain.; Department of Biochemistry and Molecular Biology, University of the Basque Country (UPV/EHU), PO Box 644, 48080, Bilbao, Spain.
Tascón I; Instituto Biofisika (CSIC-UPV/EHU), University of the Basque Country (UPV/EHU), PO Box 644, 48080, Bilbao, Spain.; Ikerbasque, Basque Foundation for Science, 48013, Bilbao, Spain.
Colom A; Instituto Biofisika (CSIC-UPV/EHU), University of the Basque Country (UPV/EHU), PO Box 644, 48080, Bilbao, Spain.; Department of Biochemistry and Molecular Biology, University of the Basque Country (UPV/EHU), PO Box 644, 48080, Bilbao, Spain.; Ikerbasque, Basque Foundation for Science, 48013, Bilbao, Spain.
Ubarretxena-Belandia I; Instituto Biofisika (CSIC-UPV/EHU), University of the Basque Country (UPV/EHU), PO Box 644, 48080, Bilbao, Spain.; Ikerbasque, Basque Foundation for Science, 48013, Bilbao, Spain.
Arrondo JLR; Instituto Biofisika (CSIC-UPV/EHU), University of the Basque Country (UPV/EHU), PO Box 644, 48080, Bilbao, Spain.; Department of Biochemistry and Molecular Biology, University of the Basque Country (UPV/EHU), PO Box 644, 48080, Bilbao, Spain.
Apellániz B; Department of Physiology, Faculty of Pharmacy, University of the Basque Country (UPV/EHU), Paseo de la Universidad, 7, 01006, Vitoria-Gasteiz, Spain.
Nieva JL; Instituto Biofisika (CSIC-UPV/EHU), University of the Basque Country (UPV/EHU), PO Box 644, 48080, Bilbao, Spain. .; Department of Biochemistry and Molecular Biology, University of the Basque Country (UPV/EHU), PO Box 644, 48080, Bilbao, Spain. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2021 Jan 14; Vol. 11 (1), pp. 1278. Date of Electronic Publication: 2021 Jan 14.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Membrane Fusion*
HIV-1/*physiology
Lipid Bilayers/*metabolism
env Gene Products, Human Immunodeficiency Virus/*metabolism
HIV Infections/virology ; Humans ; Models, Molecular ; env Gene Products, Human Immunodeficiency Virus/chemistry
Czasopismo naukowe
Tytuł:
HIV-1C env and gag Variation in the Cerebrospinal Fluid and Plasma of Patients with HIV-Associated Cryptococcal Meningitis in Botswana.
Autorzy:
Kelentse N; Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana.; School of Allied Health Professions, Faculty of Health Sciences, University of Botswana, Gaborone, Botswana.
Moyo S; Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana.; Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, MA 02115, USA.
Mogwele ML; Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana.; Department of Biological Sciences, University of Botswana, Gaborone, Botswana.
Ditshwanelo D; Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana.
Mokaleng B; Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana.; School of Allied Health Professions, Faculty of Health Sciences, University of Botswana, Gaborone, Botswana.
Moraka NO; Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana.; Department of Pathology, Stellenbosch University, Stellenbosch 7505, South Africa.
Lechiile K; Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana.; Botswana-University of Pennsylvania Partnership, Gaborone, Botswana.
Leeme TB; Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana.; Botswana-University of Pennsylvania Partnership, Gaborone, Botswana.
Lawrence DS; Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana.; Department of Clinical Research, Faculty of Infectious and Tropical Diseases, The London School of Hygiene and Tropical Medicine, London WC1E 7HT, UK.
Musonda R; Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana.; Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, MA 02115, USA.
Kasvosve I; School of Allied Health Professions, Faculty of Health Sciences, University of Botswana, Gaborone, Botswana.
Harrison TS; Centre for Global Health, Institute for Infection and Immunity, St. George's University of London, London SW17 0RE, UK.
Jarvis JN; Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana.; Botswana-University of Pennsylvania Partnership, Gaborone, Botswana.; Department of Clinical Research, Faculty of Infectious and Tropical Diseases, The London School of Hygiene and Tropical Medicine, London WC1E 7HT, UK.; Department of Medicine, Division of Infectious Diseases, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
Gaseitsiwe S; Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana.; Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, MA 02115, USA.
Pokaż więcej
Źródło:
Viruses [Viruses] 2020 Dec 07; Vol. 12 (12). Date of Electronic Publication: 2020 Dec 07.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
AIDS-Related Opportunistic Infections/*metabolism
HIV Infections/*complications
Meningitis, Cryptococcal/*etiology
Meningitis, Cryptococcal/*metabolism
env Gene Products, Human Immunodeficiency Virus/*metabolism
gag Gene Products, Human Immunodeficiency Virus/*metabolism
AIDS-Related Opportunistic Infections/blood ; AIDS-Related Opportunistic Infections/cerebrospinal fluid ; AIDS-Related Opportunistic Infections/diagnosis ; Adult ; Amino Acid Sequence ; Amino Acid Substitution ; Botswana ; CD4 Lymphocyte Count ; Cross-Sectional Studies ; Disease Susceptibility ; Female ; HIV Infections/virology ; Humans ; Immunocompromised Host ; Male ; Meningitis, Cryptococcal/blood ; Meningitis, Cryptococcal/cerebrospinal fluid ; Middle Aged ; Mutation ; RNA, Viral ; Viral Load ; env Gene Products, Human Immunodeficiency Virus/blood ; env Gene Products, Human Immunodeficiency Virus/cerebrospinal fluid ; gag Gene Products, Human Immunodeficiency Virus/blood ; gag Gene Products, Human Immunodeficiency Virus/cerebrospinal fluid
Czasopismo naukowe
Tytuł:
A Conserved Tryptophan in the Envelope Cytoplasmic Tail Regulates HIV-1 Assembly and Spread.
Autorzy:
Snetkov X; Division of Infection and Immunity, University College London, London WC1E 6BT, UK.
Haider T; Division of Infection and Immunity, University College London, London WC1E 6BT, UK.
Mesner D; Division of Infection and Immunity, University College London, London WC1E 6BT, UK.
Groves N; Molecular and Cellular Biophysics Program, Department of Biological Sciences, University of Denver, Denver, CO 80210, USA.
van Engelenburg SB; Molecular and Cellular Biophysics Program, Department of Biological Sciences, University of Denver, Denver, CO 80210, USA.
Jolly C; Division of Infection and Immunity, University College London, London WC1E 6BT, UK.
Pokaż więcej
Źródło:
Viruses [Viruses] 2022 Jan 12; Vol. 14 (1). Date of Electronic Publication: 2022 Jan 12.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
HIV-1/*physiology
Tryptophan/*metabolism
Virus Assembly/*physiology
env Gene Products, Human Immunodeficiency Virus/*metabolism
CD4-Positive T-Lymphocytes ; Cell Membrane/metabolism ; HEK293 Cells ; HIV Envelope Protein gp41 ; HIV Infections/virology ; HIV-1/genetics ; HeLa Cells ; Humans ; T-Lymphocytes/metabolism ; T-Lymphocytes/virology ; Virion/metabolism ; Virus Internalization ; Virus Replication
Czasopismo naukowe
Tytuł:
Mutational networks of escape from transmitted HIV-1 infection.
Autorzy:
Akand EH; School of Mathematics and Statistics, UNSW Sydney, Kensington, NSW, Australia.
Maher SJ; College of Engineering, Mathematical and Physical Sciences, University of Exeter, Exeter, United Kingdom.
Murray JM; School of Mathematics and Statistics, UNSW Sydney, Kensington, NSW, Australia.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2020 Dec 07; Vol. 15 (12), pp. e0243391. Date of Electronic Publication: 2020 Dec 07 (Print Publication: 2020).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
HIV Envelope Protein gp160/*genetics
HIV Infections/*genetics
HIV-1/*genetics
env Gene Products, Human Immunodeficiency Virus/*genetics
Computational Biology ; Glycosylation ; HIV Envelope Protein gp160/immunology ; HIV Infections/immunology ; HIV Infections/virology ; HIV-1/pathogenicity ; Humans ; Immune Evasion/genetics ; Immunity/genetics ; Immunity/immunology ; Mutation/genetics ; Protein Binding/genetics ; env Gene Products, Human Immunodeficiency Virus/immunology
Czasopismo naukowe
Tytuł:
Structural and functional evaluation of de novo-designed, two-component nanoparticle carriers for HIV Env trimer immunogens.
Autorzy:
Antanasijevic A; Department of Integrative, Structural and Computational Biology, Scripps Research, La Jolla, California, United States of America.; International AIDS Vaccine Initiative Neutralizing Antibody Center, the Collaboration for AIDS Vaccine Discovery (CAVD) and Scripps Consortium for HIV/AIDS Vaccine Development (CHAVD), Scripps Research, La Jolla, California, United States of America.
Ueda G; Institute for Protein Design, Department of Biochemistry, University of Washington, Seattle, Washington, United States of America.
Brouwer PJM; Academic Medical Center (AMC), University of Amsterdam, Amsterdam, Netherlands.
Copps J; Department of Integrative, Structural and Computational Biology, Scripps Research, La Jolla, California, United States of America.; International AIDS Vaccine Initiative Neutralizing Antibody Center, the Collaboration for AIDS Vaccine Discovery (CAVD) and Scripps Consortium for HIV/AIDS Vaccine Development (CHAVD), Scripps Research, La Jolla, California, United States of America.
Huang D; Department of Immunology and Microbiology, Scripps Research, La Jolla, California, United States of America.
Allen JD; School of Biological Sciences, University of Southampton, Southampton, United Kingdom.
Cottrell CA; Department of Integrative, Structural and Computational Biology, Scripps Research, La Jolla, California, United States of America.; International AIDS Vaccine Initiative Neutralizing Antibody Center, the Collaboration for AIDS Vaccine Discovery (CAVD) and Scripps Consortium for HIV/AIDS Vaccine Development (CHAVD), Scripps Research, La Jolla, California, United States of America.
Yasmeen A; Weill Cornell Medicine, Cornell University, New York, New York, United States of America.
Sewall LM; Department of Integrative, Structural and Computational Biology, Scripps Research, La Jolla, California, United States of America.
Bontjer I; Academic Medical Center (AMC), University of Amsterdam, Amsterdam, Netherlands.
Ketas TJ; Weill Cornell Medicine, Cornell University, New York, New York, United States of America.
Turner HL; Department of Integrative, Structural and Computational Biology, Scripps Research, La Jolla, California, United States of America.; International AIDS Vaccine Initiative Neutralizing Antibody Center, the Collaboration for AIDS Vaccine Discovery (CAVD) and Scripps Consortium for HIV/AIDS Vaccine Development (CHAVD), Scripps Research, La Jolla, California, United States of America.
Berndsen ZT; Department of Integrative, Structural and Computational Biology, Scripps Research, La Jolla, California, United States of America.; International AIDS Vaccine Initiative Neutralizing Antibody Center, the Collaboration for AIDS Vaccine Discovery (CAVD) and Scripps Consortium for HIV/AIDS Vaccine Development (CHAVD), Scripps Research, La Jolla, California, United States of America.
Montefiori DC; Department of Surgery, Duke University Medical Center, Durham, North Carolina, United States of America.
Klasse PJ; Weill Cornell Medicine, Cornell University, New York, New York, United States of America.
Crispin M; School of Biological Sciences, University of Southampton, Southampton, United Kingdom.
Nemazee D; Department of Immunology and Microbiology, Scripps Research, La Jolla, California, United States of America.
Moore JP; Weill Cornell Medicine, Cornell University, New York, New York, United States of America.
Sanders RW; Academic Medical Center (AMC), University of Amsterdam, Amsterdam, Netherlands.
King NP; Institute for Protein Design, Department of Biochemistry, University of Washington, Seattle, Washington, United States of America.
Baker D; Institute for Protein Design, Department of Biochemistry, University of Washington, Seattle, Washington, United States of America.; Howard Hughes Medical Institute, Chevy Chase, Maryland, United States of America.
Ward AB; Department of Integrative, Structural and Computational Biology, Scripps Research, La Jolla, California, United States of America.; International AIDS Vaccine Initiative Neutralizing Antibody Center, the Collaboration for AIDS Vaccine Discovery (CAVD) and Scripps Consortium for HIV/AIDS Vaccine Development (CHAVD), Scripps Research, La Jolla, California, United States of America.
Pokaż więcej
Źródło:
PLoS pathogens [PLoS Pathog] 2020 Aug 11; Vol. 16 (8), pp. e1008665. Date of Electronic Publication: 2020 Aug 11 (Print Publication: 2020).
Typ publikacji:
Evaluation Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms:
HIV Antibodies/*immunology
HIV Antigens/*immunology
HIV Infections/*immunology
HIV-1/*immunology
Nanoparticles/*chemistry
env Gene Products, Human Immunodeficiency Virus/*chemistry
env Gene Products, Human Immunodeficiency Virus/*immunology
Animals ; Epitopes/immunology ; Female ; HIV Infections/virology ; Humans ; Immunization ; Nanoparticles/administration & dosage ; Rabbits ; env Gene Products, Human Immunodeficiency Virus/genetics
Czasopismo naukowe
Tytuł:
Defective HIV-1 envelope gene promotes the evolution of the infectious strain through recombination in vitro.
Autorzy:
Wei H; NHC Key Laboratory of Systems Biology of Pathogens, Institute of Pathogen Biology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, P. R. China.; Center for AIDS Research, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, P. R. China.
Yu D; NHC Key Laboratory of Systems Biology of Pathogens, Institute of Pathogen Biology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, P. R. China.; Center for AIDS Research, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, P. R. China.
Geng X; NHC Key Laboratory of Systems Biology of Pathogens, Institute of Pathogen Biology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, P. R. China.; Center for AIDS Research, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, P. R. China.
He Y; NHC Key Laboratory of Systems Biology of Pathogens, Institute of Pathogen Biology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, P. R. China. .; Center for AIDS Research, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, P. R. China. .
Pokaż więcej
Źródło:
BMC infectious diseases [BMC Infect Dis] 2020 Aug 04; Vol. 20 (1), pp. 569. Date of Electronic Publication: 2020 Aug 04.
Typ publikacji:
Journal Article
MeSH Terms:
Evolution, Molecular*
HIV Infections/*pathology
HIV-1/*physiology
env Gene Products, Human Immunodeficiency Virus/*genetics
HEK293 Cells ; HIV Infections/virology ; HIV-1/classification ; HIV-1/genetics ; Humans ; Phylogeny ; Plasmids/genetics ; Plasmids/metabolism ; Recombination, Genetic ; env Gene Products, Human Immunodeficiency Virus/chemistry ; env Gene Products, Human Immunodeficiency Virus/metabolism
Czasopismo naukowe
Tytuł:
HIV-1 Envelope Glycoprotein Cell Surface Localization Is Associated with Antibody-Induced Internalization.
Autorzy:
Anand SP; Centre de Recherche du CHUM, Montreal, QC H2X 0A9, Canada.; Department of Microbiology and Immunology, McGill University, Montreal, QC H3A 2B4, Canada.
Prévost J; Centre de Recherche du CHUM, Montreal, QC H2X 0A9, Canada.; Département de Microbiologie, Infectiologie et Immunologie, Université de Montréal, Montreal, QC H2X 0A9, Canada.
Descôteaux-Dinelle J; Centre de Recherche du CHUM, Montreal, QC H2X 0A9, Canada.; Département de Microbiologie, Infectiologie et Immunologie, Université de Montréal, Montreal, QC H2X 0A9, Canada.
Richard J; Centre de Recherche du CHUM, Montreal, QC H2X 0A9, Canada.; Département de Microbiologie, Infectiologie et Immunologie, Université de Montréal, Montreal, QC H2X 0A9, Canada.
Nguyen DN; Infectious Disease Division, Department of Medicine, Uniformed Services University of the Health Sciences, Bethesda, MD 20814-4712, USA.
Medjahed H; Centre de Recherche du CHUM, Montreal, QC H2X 0A9, Canada.
Chen HC; Department of Chemistry, University of Pennsylvania, Philadelphia, PA 19104, USA.
Smith AB 3rd; Department of Chemistry, University of Pennsylvania, Philadelphia, PA 19104, USA.
Pazgier M; Infectious Disease Division, Department of Medicine, Uniformed Services University of the Health Sciences, Bethesda, MD 20814-4712, USA.
Finzi A; Centre de Recherche du CHUM, Montreal, QC H2X 0A9, Canada.; Department of Microbiology and Immunology, McGill University, Montreal, QC H3A 2B4, Canada.; Département de Microbiologie, Infectiologie et Immunologie, Université de Montréal, Montreal, QC H2X 0A9, Canada.
Pokaż więcej
Źródło:
Viruses [Viruses] 2021 Sep 29; Vol. 13 (10). Date of Electronic Publication: 2021 Sep 29.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Virus Internalization*
Broadly Neutralizing Antibodies/*immunology
Endocytosis/*immunology
HIV Antibodies/*immunology
HIV-1/*immunology
env Gene Products, Human Immunodeficiency Virus/*immunology
env Gene Products, Human Immunodeficiency Virus/*metabolism
CD4 Antigens/metabolism ; Epitopes/immunology ; HEK293 Cells ; HIV Envelope Protein gp120/immunology ; HIV Envelope Protein gp120/metabolism ; Humans ; Molecular Conformation
Czasopismo naukowe
Tytuł:
Longitudinal analysis of subtype C envelope tropism for memory CD4 T cell subsets over the first 3 years of untreated HIV-1 infection.
Autorzy:
Gartner MJ; School of Health and Biomedical Sciences, RMIT University, Bundoora, Melbourne, VIC, Australia.; The Peter Doherty Institute for Infection and Immunity, University of Melbourne and Royal Melbourne Hospital, Melbourne, VIC, Australia.
Gorry PR; School of Health and Biomedical Sciences, RMIT University, Bundoora, Melbourne, VIC, Australia.
Tumpach C; The Peter Doherty Institute for Infection and Immunity, University of Melbourne and Royal Melbourne Hospital, Melbourne, VIC, Australia.
Zhou J; School of Health and Biomedical Sciences, RMIT University, Bundoora, Melbourne, VIC, Australia.
Dantanarayana A; The Peter Doherty Institute for Infection and Immunity, University of Melbourne and Royal Melbourne Hospital, Melbourne, VIC, Australia.
Chang JJ; The Peter Doherty Institute for Infection and Immunity, University of Melbourne and Royal Melbourne Hospital, Melbourne, VIC, Australia.
Angelovich TA; School of Health and Biomedical Sciences, RMIT University, Bundoora, Melbourne, VIC, Australia.; Life Sciences, Burnet Institute, Melbourne, VIC, Australia.
Ellenberg P; The Peter Doherty Institute for Infection and Immunity, University of Melbourne and Royal Melbourne Hospital, Melbourne, VIC, Australia.
Laumaea AE; School of Health and Biomedical Sciences, RMIT University, Bundoora, Melbourne, VIC, Australia.; Département de Microbiologie, Infectiologie et Immunologie, Université de Montréal, Montreal, QC, Canada.
Nonyane M; Centre for HIV and STIs, National Institute for Communicable Diseases (NICD) of the National Health Laboratory Service (NHLS), Johannesburg, South Africa.
Moore PL; Centre for HIV and STIs, National Institute for Communicable Diseases (NICD) of the National Health Laboratory Service (NHLS), Johannesburg, South Africa.; Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.; Centre for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu-Natal, Durban, South Africa.
Lewin SR; The Peter Doherty Institute for Infection and Immunity, University of Melbourne and Royal Melbourne Hospital, Melbourne, VIC, Australia.; Department of Infectious Diseases, Monash University and Alfred Hospital, Melbourne, Australia.
Churchill MJ; School of Health and Biomedical Sciences, RMIT University, Bundoora, Melbourne, VIC, Australia.
Flynn JK; School of Health and Biomedical Sciences, RMIT University, Bundoora, Melbourne, VIC, Australia. .; The Peter Doherty Institute for Infection and Immunity, University of Melbourne and Royal Melbourne Hospital, Melbourne, VIC, Australia. .; School of Clinical Sciences, Monash University, Melbourne, VIC, Australia. .
Roche M; School of Health and Biomedical Sciences, RMIT University, Bundoora, Melbourne, VIC, Australia. .; The Peter Doherty Institute for Infection and Immunity, University of Melbourne and Royal Melbourne Hospital, Melbourne, VIC, Australia. .
Pokaż więcej
Źródło:
Retrovirology [Retrovirology] 2020 Aug 06; Vol. 17 (1), pp. 24. Date of Electronic Publication: 2020 Aug 06.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Viral Tropism*
CD4-Positive T-Lymphocytes/*immunology
HIV Infections/*virology
HIV-1/*physiology
T-Lymphocyte Subsets/*immunology
env Gene Products, Human Immunodeficiency Virus/*metabolism
Adult ; CD4-Positive T-Lymphocytes/metabolism ; CD4-Positive T-Lymphocytes/virology ; Female ; Genetic Variation ; HIV Infections/immunology ; HIV-1/classification ; HIV-1/genetics ; Humans ; Immunologic Memory ; Longitudinal Studies ; Phylogeny ; Receptors, HIV/metabolism ; T-Lymphocyte Subsets/metabolism ; T-Lymphocyte Subsets/virology ; env Gene Products, Human Immunodeficiency Virus/genetics
Czasopismo naukowe
Tytuł:
Strategies for induction of HIV-1 envelope-reactive broadly neutralizing antibodies.
Autorzy:
Williams WB; Human Vaccine Institute, Duke University School of Medicine, Durham, North Carolina, USA.; Department of Surgery, Duke University School of Medicine, Durham, North Carolina, USA.
Wiehe K; Human Vaccine Institute, Duke University School of Medicine, Durham, North Carolina, USA.; Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA.
Saunders KO; Human Vaccine Institute, Duke University School of Medicine, Durham, North Carolina, USA.; Department of Surgery, Duke University School of Medicine, Durham, North Carolina, USA.; Department of Immunology, Duke University School of Medicine, Durham, North Carolina, USA.
Haynes BF; Human Vaccine Institute, Duke University School of Medicine, Durham, North Carolina, USA.; Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA.; Department of Immunology, Duke University School of Medicine, Durham, North Carolina, USA.
Pokaż więcej
Źródło:
Journal of the International AIDS Society [J Int AIDS Soc] 2021 Nov; Vol. 24 Suppl 7, pp. e25831.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Review
MeSH Terms:
AIDS Vaccines*
HIV Infections*/prevention & control
HIV-1*
env Gene Products, Human Immunodeficiency Virus/*immunology
Antibodies, Neutralizing ; Broadly Neutralizing Antibodies ; HIV Antibodies ; Humans
Czasopismo naukowe
Tytuł:
Optimal priming of poxvirus vector (NYVAC)-based HIV vaccine regimens for T cell responses requires three DNA injections. Results of the randomized multicentre EV03/ANRS VAC20 Phase I/II Trial.
Autorzy:
Lévy Y; Vaccine Research Institute, Université Paris-Est Créteil, Faculté de Médecine, INSERM U955, équipe 16, Créteil, France.; Assistance Publique-Hôpitaux de Paris, Groupe Henri-Mondor Albert-Chenevier, Service d'Immunologie Clinique, Créteil, France.
Lacabaratz C; Vaccine Research Institute, Université Paris-Est Créteil, Faculté de Médecine, INSERM U955, équipe 16, Créteil, France.
Ellefsen-Lavoie K; Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland.
Stöhr W; MRC Clinical Trials Unit at UCL, London, United Kingdom.
Lelièvre JD; Vaccine Research Institute, Université Paris-Est Créteil, Faculté de Médecine, INSERM U955, équipe 16, Créteil, France.; Assistance Publique-Hôpitaux de Paris, Groupe Henri-Mondor Albert-Chenevier, Service d'Immunologie Clinique, Créteil, France.
Bart PA; Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland.
Launay O; Université de Paris, Faculté de médecine Paris Descartes; Inserm, CIC 1417, F-CRIN I-REIVAC; Assistance Publique-Hôpitaux de Paris, CIC Cochin Pasteur, Paris, France.
Weber J; Imperial College London, London, United Kingdom.
Salzberger B; University Hospital, Institute of Clinical Microbiology and Hygiene, University of Regensburg, Regensburg, Germany.
Wiedemann A; Vaccine Research Institute, Université Paris-Est Créteil, Faculté de Médecine, INSERM U955, équipe 16, Créteil, France.
Surenaud M; Vaccine Research Institute, Université Paris-Est Créteil, Faculté de Médecine, INSERM U955, équipe 16, Créteil, France.
Koelle DM; Department of Medicine & Department of Global Health, University of Washington, Fred Hutchinson Cancer Research Center Seattle, Washington, United States of America.
Wolf H; University Hospital, Institute of Clinical Microbiology and Hygiene, University of Regensburg, Regensburg, Germany.
Wagner R; University Hospital, Institute of Clinical Microbiology and Hygiene, University of Regensburg, Regensburg, Germany.
Rieux V; Vaccine Research Institute, Université Paris-Est Créteil, Faculté de Médecine, INSERM U955, équipe 16, Créteil, France.; ANRS, Paris, France.
Montefiori DC; Department of Surgery, Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, United States of America.
Yates NL; Department of Surgery, Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, United States of America.
Tomaras GD; Department of Surgery, Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, United States of America.
Gottardo R; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.; Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.
Mayer B; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.
Ding S; EuroVacc Foundation, Lausanne, Switzerland.
Thiébaut R; Inserm, Bordeaux Population Health Research Center, UMR 1219, University Bordeaux, ISPED, CIC 1401-EC, Univ Bordeaux, Bordeaux, France.; CHU de Bordeaux, pôle de santé publique, Bordeaux, France.; INRIA SISTM, Talence, France.
McCormack S; MRC Clinical Trials Unit at UCL, London, United Kingdom.
Chêne G; Inserm, Bordeaux Population Health Research Center, UMR 1219, University Bordeaux, ISPED, CIC 1401-EC, Univ Bordeaux, Bordeaux, France.; CHU de Bordeaux, pôle de santé publique, Bordeaux, France.
Pantaleo G; Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland.; Swiss Vaccine Research Institute, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.
Pokaż więcej
Źródło:
PLoS pathogens [PLoS Pathog] 2020 Jun 26; Vol. 16 (6), pp. e1008522. Date of Electronic Publication: 2020 Jun 26 (Print Publication: 2020).
Typ publikacji:
Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
AIDS Vaccines/*immunology
Genetic Vectors/*immunology
HIV Antigens/*immunology
Poxviridae/*immunology
Vaccines, DNA/*immunology
env Gene Products, Human Immunodeficiency Virus/*immunology
AIDS Vaccines/administration & dosage ; AIDS Vaccines/genetics ; Adolescent ; Adult ; CD8-Positive T-Lymphocytes/immunology ; Female ; Genetic Vectors/administration & dosage ; Genetic Vectors/genetics ; HIV Antigens/administration & dosage ; HIV Antigens/genetics ; Humans ; Interferon-gamma/immunology ; Male ; Middle Aged ; Poxviridae/genetics ; T-Lymphocytes, Helper-Inducer/metabolism ; Vaccines, DNA/administration & dosage ; Vaccines, DNA/genetics ; env Gene Products, Human Immunodeficiency Virus/administration & dosage ; env Gene Products, Human Immunodeficiency Virus/genetics
Czasopismo naukowe
Tytuł:
A recombinant gp145 Env glycoprotein from HIV-1 expressed in two different cell lines: Effects on glycosylation and antigenicity.
Autorzy:
González-Feliciano JA; Molecular Sciences Research Center Inc., University of Puerto Rico, San Juan, Puerto Rico.
Akamine P; Molecular Sciences Research Center Inc., University of Puerto Rico, San Juan, Puerto Rico.
Capó-Vélez CM; Molecular Sciences Research Center Inc., University of Puerto Rico, San Juan, Puerto Rico.
Delgado-Vélez M; Molecular Sciences Research Center Inc., University of Puerto Rico, San Juan, Puerto Rico.
Dussupt V; U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America.; Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, Maryland, United States of America.
Krebs SJ; U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America.; Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, Maryland, United States of America.
Wojna V; Division of Neurology, Internal Medicine Department and NeuroHIV Research Program, University of Puerto Rico, Medical Sciences Campus, San Juan, Puerto Rico.
Polonis VR; U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America.
Baerga-Ortiz A; Molecular Sciences Research Center Inc., University of Puerto Rico, San Juan, Puerto Rico.; Department of Biochemistry, University of Puerto Rico, Medical Sciences Campus, San Juan, Puerto Rico.
Lasalde-Dominicci JA; Molecular Sciences Research Center Inc., University of Puerto Rico, San Juan, Puerto Rico.; Department of Biology, University of Puerto Rico, Rio Piedras Campus, San Juan, Puerto Rico.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2020 Jun 19; Vol. 15 (6), pp. e0231679. Date of Electronic Publication: 2020 Jun 19 (Print Publication: 2020).
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms:
Glycopeptides/*analysis
HIV Antibodies/*immunology
HIV-1/*metabolism
env Gene Products, Human Immunodeficiency Virus/*immunology
Adult ; Animals ; Antibodies, Neutralizing/immunology ; Antibodies, Viral/blood ; Antibodies, Viral/immunology ; Antigen-Antibody Reactions ; CHO Cells ; Cricetinae ; Cricetulus ; Female ; Glycosylation ; HEK293 Cells ; Humans ; Middle Aged ; Recombinant Proteins/biosynthesis ; Recombinant Proteins/immunology ; Recombinant Proteins/isolation & purification ; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization ; Young Adult ; env Gene Products, Human Immunodeficiency Virus/genetics ; env Gene Products, Human Immunodeficiency Virus/metabolism
Czasopismo naukowe
Tytuł:
Gene editing in CHO cells to prevent proteolysis and enhance glycosylation: Production of HIV envelope proteins as vaccine immunogens.
Autorzy:
Li SW; Department of Chemistry and Biochemistry, University of California Santa Cruz, Santa Cruz, California, United States of America.; Department of Biomolecular Engineering, University of California Santa Cruz, Santa Cruz, California, United States of America.
Wright M; Department of Biomolecular Engineering, University of California Santa Cruz, Santa Cruz, California, United States of America.
Healey JF; Department of Pediatrics, Emory University, Atlanta, Georgia, United States of America.
Hutchinson JM; Department of Biomolecular Engineering, University of California Santa Cruz, Santa Cruz, California, United States of America.
O'Rourke S; Department of Biomolecular Engineering, University of California Santa Cruz, Santa Cruz, California, United States of America.
Mesa KA; Department of Biomolecular Engineering, University of California Santa Cruz, Santa Cruz, California, United States of America.
Lollar P; Department of Pediatrics, Emory University, Atlanta, Georgia, United States of America.
Berman PW; Department of Biomolecular Engineering, University of California Santa Cruz, Santa Cruz, California, United States of America.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2020 May 29; Vol. 15 (5), pp. e0233866. Date of Electronic Publication: 2020 May 29 (Print Publication: 2020).
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
Gene Editing*
Proteolysis*
AIDS Vaccines/*immunology
env Gene Products, Human Immunodeficiency Virus/*immunology
Alleles ; Amino Acid Sequence ; Animals ; Antibodies, Monoclonal/immunology ; Antibodies, Neutralizing/immunology ; Binding Sites ; CHO Cells ; Consensus Sequence ; Cricetinae ; Cricetulus ; Factor VIII/metabolism ; Glycosylation ; Humans ; Polysaccharides/metabolism ; Protein Domains ; Recombinant Proteins/metabolism ; Serine Proteases/chemistry ; Serine Proteases/metabolism ; Structural Homology, Protein ; Substrate Specificity ; Thrombin/metabolism ; env Gene Products, Human Immunodeficiency Virus/chemistry
Czasopismo naukowe
Tytuł:
The Interplay between HIV-1 Gag Binding to the Plasma Membrane and Env Incorporation.
Autorzy:
Murphy RE; Department of Microbiology, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
Saad JS; Department of Microbiology, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
Pokaż więcej
Źródło:
Viruses [Viruses] 2020 May 16; Vol. 12 (5). Date of Electronic Publication: 2020 May 16.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Review
MeSH Terms:
Cell Membrane/*metabolism
HIV-1/*metabolism
env Gene Products, Human Immunodeficiency Virus/*metabolism
gag Gene Products, Human Immunodeficiency Virus/*metabolism
HIV Antigens/chemistry ; HIV Antigens/metabolism ; HIV Envelope Protein gp41/chemistry ; HIV Envelope Protein gp41/metabolism ; Phosphatidylinositol 4,5-Diphosphate/metabolism ; Protein Binding ; Protein Conformation ; Virus Assembly ; env Gene Products, Human Immunodeficiency Virus/chemistry ; gag Gene Products, Human Immunodeficiency Virus/chemistry
Czasopismo naukowe
Tytuł:
Different adjuvanted pediatric HIV envelope vaccines induced distinct plasma antibody responses despite similar B cell receptor repertoires in infant rhesus macaques.
Autorzy:
Berendam SJ; Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, United States of America.
Morgan-Asiedu PK; Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, United States of America.
Mangan RJ; Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, United States of America.
Li SH; Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, United States of America.
Heimsath H; Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, United States of America.
Luo K; Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, United States of America.
Curtis AD 2nd; Department of Microbiology and Immunology, Children's Research Institute and Center for AIDS Research, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.
Eudailey JA; Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, United States of America.; Department of Pediatrics, Weill Cornell College of Medicine, New York City, New York, United States of America.
Fox CB; Infectious Disease Research Institute (IDRI), Seattle, Washington State, United States of America.; Department of Global Health, University of Washington, Seattle, Washington State, United States of America.
Tomai MA; 3M Center, 3 M Drug Delivery Systems, St. Paul, Minnesota, United States of America.
Phillips B; Department of Microbiology and Immunology, Children's Research Institute and Center for AIDS Research, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.
Itell HL; Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, United States of America.
Kunz E; Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, United States of America.
Hudgens M; Department of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.
Cronin K; Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, United States of America.
Wiehe K; Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, United States of America.
Alam SM; Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, United States of America.
Van Rompay KKA; California National Primate Research Center, University of California at Davis, Davis, California, United States of America.
De Paris K; Department of Microbiology and Immunology, Children's Research Institute and Center for AIDS Research, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.
Permar SR; Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, United States of America.; Department of Pediatrics, Weill Cornell College of Medicine, New York City, New York, United States of America.
Moody MA; Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, United States of America.
Fouda GG; Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, United States of America.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2021 Dec 31; Vol. 16 (12), pp. e0256885. Date of Electronic Publication: 2021 Dec 31 (Print Publication: 2021).
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
AIDS Vaccines/*blood
AIDS Vaccines/*immunology
Adjuvants, Immunologic/*pharmacology
Antibody Formation/*immunology
Receptors, Antigen, B-Cell/*metabolism
env Gene Products, Human Immunodeficiency Virus/*immunology
Animals ; Antibody Formation/drug effects ; Child ; Complementarity Determining Regions ; Epitopes/immunology ; Humans ; Immunization ; Immunoglobulin Heavy Chains/metabolism ; Immunologic Memory/drug effects ; Macaca mulatta ; Somatic Hypermutation, Immunoglobulin ; Toll-Like Receptors/agonists ; Toll-Like Receptors/metabolism
Czasopismo naukowe
Tytuł:
Structure dynamics of HIV-1 Env trimers on native virions engaged with living T cells.
Autorzy:
Carlon-Andres I; Department of Infectious Diseases, King's College London, Faculty of Life Sciences & Medicine, London, United Kingdom. .; Randall Division of Cell and Molecular Biophysics, King's College London, London, United Kingdom. .; Division of Structural Biology, Wellcome Centre for Human Genetics, University of Oxford, Oxford, United Kingdom. .
Malinauskas T; Division of Structural Biology, Wellcome Centre for Human Genetics, University of Oxford, Oxford, United Kingdom.
Padilla-Parra S; Department of Infectious Diseases, King's College London, Faculty of Life Sciences & Medicine, London, United Kingdom. sergio.padilla_.; Randall Division of Cell and Molecular Biophysics, King's College London, London, United Kingdom. sergio.padilla_.; Division of Structural Biology, Wellcome Centre for Human Genetics, University of Oxford, Oxford, United Kingdom. sergio.padilla_.
Pokaż więcej
Źródło:
Communications biology [Commun Biol] 2021 Oct 27; Vol. 4 (1), pp. 1228. Date of Electronic Publication: 2021 Oct 27.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
HIV-1/*physiology
T-Lymphocytes/*virology
Viral Proteins/*metabolism
Virion/*metabolism
env Gene Products, Human Immunodeficiency Virus/*metabolism
Virus Internalization
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies